Skip to content

The Efficacy of Ultrasound-Guided Capsule-Preserving Hydrodilatation with Corticosteroid Versus Conventional Corticosteroid Injection in Shoulder Adhesive Capsulitis A Randomized, Double-blinded, Controlled Trial

A Comparative Study of Range of Motion of Shoulder between Ultrasound Guided Hydrodilatation with Corticosteroid and Conventional Corticosteroid Injection alone in Adhesive Capsulitis: A Randomized, Controlled and Double-blinded Study

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210217005
Enrollment
52
Registered
2021-02-17
Start date
2020-12-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adhesive capsulitis patient with not improve by physical therapy adhesive capsulitis ultrasound hydrodilatation

Interventions

arm1 (intervention) volume 20 ml : triamcinolone acetonide (10:1) 4 ml 1% lidocaine 6 ml normal saline 10 ml arm2 (controlled) volume 5 ml triamcinolone acetonide (10:1) 4 ml 1% lidocaine 1 ml injec
Active Comparator Drug
arm1 (intervention) volume 20 ml arm2 (controlled) volume 5 ml

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. patient with adhesive capsulitis who limit of passive motion greater than 30 degree in two planes of movement. 2. age > 18 years 3. patient who received physical therapy more than 1 month and has NPRS at least 4 4. Graduated elementary school or can read Thai language

Exclusion criteria

Exclusion criteria: 1. previous steroid injection to shoulder joint or manipulation under general anesthesia 2. they had any of the following calcification of the rotator cuff, rotator cuff tear, disorders of the biceps tendon or acromioclavicular joint. 3. secondary adhesive capsulitis ex. cancer, rheumatoid arthritis, infectious arthritis, stroke or fracture 4.uncontrolled diabetes 5. major depression 6. bleeding disorder 7. allergic to steriod, lidocaine or normal saline

Design outcomes

Primary

MeasureTime frame
Shoulder range of motion at6 weeks after end of the intervention goniometer

Secondary

MeasureTime frame
Patient reported outcome before and after 1,6 weeks after intervention the Thai version of the Shoulder Pain and Disability Index, Thai SPADI),Patient reported outcome before and after 1,6 weeks after intervention the Thai version of the Oxford Shoulder Score, OSS-TH,pain before and after 1,6 weeks after intervention NPRS

Countries

Thailand

Contacts

Public ContactWannapa poonnark

Chaoprayayommarat Hospital

poonimena@gmail.com035514999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026